Navigation Links
ePharmaSolutions Launches New Application to Streamline Single Sign-On and User Account Provisioning for Sponsors Using Multiple Clinical Trial Technologies
Date:4/12/2011

CONSHOHOCKEN, Pa., April 12, 2011 /PRNewswire/ -- One of the more cumbersome tasks for study teams is to manage the user administration and provisioning process into all of the technologies used to conduct clinical trials today.  ePharmaSolutions has developed an innovative solution to streamline this process to one set of credentials and one technology solution regardless of the number of vendors involved in a given study.

"The Vendor Integration Manager (VIM) is now being used on dozens of studies in more than 60 countries and provides study teams with a single user interface to manage the user provisioning process for almost every vendor involved in clinical trials today," stated Lance Converse, ePharmaSolutions founder and CEO.  "Our clients complained about the need to complete up to 10 different spreadsheets each time a user is added or edited through the study, which on large studies is a difficult task that is ridden with errors," Converse added.

A typical clinical study can require up to 10 unique technology vendors that each has their own account activation and user provisioning forms and processes.  This is cumbersome for clinical study managers conducting large studies who are required to complete these forms each time a user is added or edited throughout a study.  For larger studies, access control to as many as 4,000 unique users in 10 systems with different roles and naming conventions must be maintained and updated in a validated environment.

"The Vendor Integration Manager works as the system of record for each user in the study and auto-completes each leading technology vendor's user account provisioning forms in the exact format and process they require saving study teams an enormous amount of time and avoiding countless mistakes," Converse continued.  "We have 220,000 active users in our system, each with a unique user credential; the VIM is one step closer to our goal of providing single sign-on solutions for the entire clinical research industry."   For a short demonstration of the VIM, go to www.epharmasolutions.com/vim/ or stop by booth 331 at the Bio-IT Conference April 12th through April 14th 2011.

About ePharmaSolutions

ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals.   ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 220,000 clinical researchers in 107 countries for the top 20 pharmaceutical companies in the world.  ePharmaSolutions is headquartered in Philadelphia with offices in London. For more information visit www.epharmasolutions.com or call 610-832-9915.  Follow us on LinkedIn and Facebook.


'/>"/>
SOURCE ePharmaSolutions
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. Mylan Launches Generic Version of Sandostatin®
2. Rules-Based Medicine Launches OncologyMAP® to Advance Cancer-Related Drug and Diagnostic Development
3. Finesse Launches the VirtualTransmitter Module and TruFluor Transmitter Blades for Seamless Integration of Single-Use Sensors Into Bioreactor Control
4. Intrasphere Technologies Launches SafetyXpress(TM) for Oracle(R) Argus Safety
5. Sigma® Life Science Launches Suite of Knockout Rats to Model Parkinsons Disease
6. M-3 Information, a Leader in Expert Behavioral Health Solutions, Launches M3Clinician.com
7. Sigma® Life Science Launches Pre-designed CompoZr® Knockout Zinc Finger Nucleases for Entire Human Genome
8. MO BIO Laboratories, Inc. Launches Dye Dots™ Dry Gel Loading Dye
9. Dyadic International Launches High Performance Enzyme for Pulp and Paper Industry Using New C1 Production Platform
10. Tufts Launches Institute for Biopharmaceutical Partnerships
11. MediVet-America, Leading Animal Stem Cell Developer, Launches MediVet Lab Services
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:10/11/2017)... Md. (PRWEB) , ... October 11, 2017 , ... ... digital pathology, announced today it will be hosting a Webinar titled, “Pathology is ... Advanced Pathology Associates , on digital pathology adoption best practices and how Proscia ...
(Date:10/11/2017)... ... October 11, 2017 , ... ... has granted orphan drug designation to SBT-100, its novel anti-STAT3 (Signal Transducer and ... of osteosarcoma. SBT-100 is able to cross the cell membrane and bind intracellular ...
(Date:10/10/2017)... , Oct. 10, 2017 International research firm Parks ... Strategy, will speak at the TMA 2017 Annual Meeting , October ... trends in the residential home security market and how smart safety and ... Parks ... "The residential ...
(Date:10/9/2017)... ... ... The award-winning American Farmer television series will feature 3 Bar Biologics in an ... on RFD-TV. , With global population estimates nearing ten billion people by 2050, ... a growing nation. At the same time, many of our valuable resources are becoming ...
Breaking Biology Technology:
(Date:5/6/2017)... , May 5, 2017 ... just announced a new breakthrough in biometric authentication ... exploits quantum mechanical properties to perform biometric authentication. These ... smart semiconductor material created by Ram Group and ... finance, entertainment, transportation, supply chains and security. Ram ...
(Date:4/17/2017)... -- NXT-ID, Inc. (NASDAQ: NXTD ) ("NXT-ID" or ... 2016 Annual Report on Form 10-K on Thursday April 13, 2017 ... ... Investor Relations section of the Company,s website at http://www.nxt-id.com  under ... http://www.sec.gov . 2016 Year Highlights: ...
(Date:4/11/2017)... , Apr. 11, 2017 Research and ... Market 2017-2021" report to their offering. ... The global eye tracking market to grow at a ... report, Global Eye Tracking Market 2017-2021, has been prepared based on ... covers the market landscape and its growth prospects over the coming ...
Breaking Biology News(10 mins):